HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lancôme Counter Unveiled As Next Generation Design

This article was originally published in The Rose Sheet

Executive Summary

Lancôme unveiled a new counter featuring significantly more space and a lighter, brighter design at Bloomingdale's in New York City Oct. 12

You may also be interested in...



Lancôme Retail Store Opens Stateside As First In A “Planned Series”

The first Lancôme freestanding boutique in the U.S. opened in the Short Hills Mall in northern New Jersey recently, with the company announcing plans to open a second store in Manhattan. While the L'Oréal division said the Short Hills store is the first in a "planned series," the firm has not yet unveiled additional expansion details

Lancôme Retail Store Opens Stateside As First In A “Planned Series”

The first Lancôme freestanding boutique in the U.S. opened in the Short Hills Mall in northern New Jersey recently, with the company announcing plans to open a second store in Manhattan. While the L'Oréal division said the Short Hills store is the first in a "planned series," the firm has not yet unveiled additional expansion details

Resurface Peel To Debut As Lancôme’s Priciest Skin Care Offering

Lancôme Resurface Peel resurfacing and soothing system is formulated with 8% glycolic acid and 5% Physio-Peel Enhancer to remove the outer layer of skin, revealing a radiant appearance without the signs of environmental damage, the L'Oréal division said

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012533

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel